Founded

Address

BioVentures Investors LLC
101 Main Street
Suite 1750
Cambridge, MA 02142
United States

Open map


Recent investment activity

Tags
KANDO id: 21471

Corporate information

Registration country

Funds managed

Fund Type Vintage Currency Committed capital
BioVentures Investors IV LP Venture

Funding rounds


Investment activity status
Active investor

Selected investments

Displaying 1 - 20 of 22
Profile Country Date Funding
Cardiosolutions Inc Cardiosolutions, Inc. is a development stage company focused on a novel percutaneous alternative to open heart surgery . N/A
Enanta Pharmaceuticals Inc Enanta Pharmaceuticals is a research and development company. N/A
HealthCare IT Inc N/A
Hydra Biosciences Inc N/A
HydroCision Inc HydroCision is the leading developer, manufacturer, and marketer of fluidjet based surgical tools for the spine market. N/A
New Chemical Entities With the advent of genomics, NCE developed targeted libraries of potential pharmaceutical compounds, geared toward protein interactions. N/A
Phase Forward Inc N/A
Rcadia Medical Imaging Ltd. Develops and markets proprietary systems for computerized analysis of medical images. N/A
Spirus Medical LLC N/A
Vernalis Pharmaceutical company N/A
Zalicus Inc Combination drug development N/A
Biolex Therapeutics Inc Series D
Claros Diagnostics Inc point-of-care medical diagnostic company Series A
Claros Diagnostics Inc point-of-care medical diagnostic company Series B
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. Series B
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. Series C
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. Series D
Medtronic Inc Medical technology company specializing in implantable and invasive therapies. N/A
Momelan Technologies Inc MoMelan is developing a proprietary device platform for mechanically expanding autologous epidermal tissue for use in dermatologic conditions. N/A
Sciona Inc Provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. Series C

Financials